よむ、つかう、まなぶ。
【別添】新型コロナウイルス感染症（COVID-19）診療の手引き別冊罹患後症状のマネジメント（第３.０版） (27 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00402.html |
| 出典情報 | 新型コロナウイルス感染症（COVID-19）診療の手引き別冊罹患後症状のマネジメント（第3.0版）（10／20）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
●新型コロナウイルス感染症（COVID-19） 診療の手引き
別冊
罹患後症状のマネジメント・第 3.0 版 ● 3 呼吸器症状へのアプローチ
◆引用・参考文献◆
・厚生労働省特別研究事業．COVID-19 感染回復後の後遺障害の実態調査（横山班）
，および新型コロナウイルス感染症
（COVID-19）の長期合併症の実態把握と病態生理解明に向けた基盤研究（福永班）
COVID-19 感染回復後の後遺障害の実態調査 | 厚生労働科学研究成果データベース (niph.go.jp) および新型コロナウイルス
感染症（COVID-19）の長期合併症の実態把握と病態生理解明に向けた基盤研究 | 厚生労働科学研究成果データベース (niph.
go.jp)
・Achkar M, et al. Post-COVID lung disease(s). Ann Thorac Med. Jul-Sep;17(3):137-144, 2022.
・Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and Angiogenesis in Covid-19. N Engl J Med.
383(2)：120-8, 2020.
・Alkodaymi MS, et al. Prevalence of post-acute COVID19 syndrome symptoms at different follow-up periods: a
systematic review and meta-analysis. Clin Microbiol Infect. May；28(5) : 657-666, 2022.
・Antoniou KM, et al. European respiratory society statement on long COVID-19 follow-up. Eur Respir J. Aug 4；
60(2) : 2102174, 2022.
・Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort
study. Lancet. 400：452-61, 2022.
13：917886, 2022．
・Cheon IS, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol.Nov 12;6（65）：
eabk1741, 2021.
・Daines L, et al. Characteristics and risk factors for postCOVID-19 breathlessness after hospitalisation for
COVID-19. ERJ Open Res 2023; 9: 00274-2022 [DOI: 10.1183/23120541.00274-2022].
・Fabbri L, et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis:
a systematic review and meta-analysis.Thorax Mar 25 : thoraxjnl-2021-218275, 2022.
・Faverio P, et al. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up
study. Respir Res.Mar. 21；23(1)： 65. 2022.
・Gencer A et al. Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection:
a trigger for asthma? J Asthma 2023; 60(6):1221-1226
・Han X, et al. Longitudinal Assessment of Chest CT Findings and Pulmonary Function after COVID-19 Infection.
Radiology. 2023 Apr;307(2):e222888. doi: 10.1148/radiol.222888
・Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal
cohort study. Lancet Respir Med. 2022 Sep;10(9):863-876.
・Jiménez-Rodríguez BM, et al. On the single and multiple associations of COVID-19 post-acute sequelae: 6-month
prospective cohort study. Sci Rep.Mar 1 ; 12（1）: 3402, 2022.
・Kanne JP, et al. Long-term Lung Abnormalities Associated with COVID-19 Pneumonia. Radiology. 2023
Feb;306(2):e221806. doi: 10.1148/radiol.221806.
・Mark Barash,& Vijaya Ramalingam. Post-COVID Interstitial Lung Disease and Other Lung Sequelae. Clin Chest
Med 2023;44(2):263-277
・Montani D, et al. COMEBAC Study Group.Post-acute COVID-19 syndrome. Eur Respir Rev Mar. 9；31(163)：
210185, 2022.
・Singh SJ et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to
clinical care and rehabilitation. Lancet Respir Med 2023 May 19;S2213-2600(23)00159-5. doi: 10.1016/S22132600(23)00159-5. Online ahead of print.
・Song WJ, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral
neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. Mayl；9(5)：533-544.2021.
・Stewart I et al. Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post–
COVID-19 Study. Am J Respir Crit Care Med 2023;207(6):693-・Watanabe A, et al. One-year follow-up CT
findings in COVID-19 patients: A systematic review and meta-analysis. .Respirology. 2022 Aug;27(8):605-616.
・Wu X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19related hospitalisation: a prospective study. Lancet Respir Med. Jul；9(7)：747-754. 2021.
◀︎目次
26
別冊
罹患後症状のマネジメント・第 3.0 版 ● 3 呼吸器症状へのアプローチ
◆引用・参考文献◆
・厚生労働省特別研究事業．COVID-19 感染回復後の後遺障害の実態調査（横山班）
，および新型コロナウイルス感染症
（COVID-19）の長期合併症の実態把握と病態生理解明に向けた基盤研究（福永班）
COVID-19 感染回復後の後遺障害の実態調査 | 厚生労働科学研究成果データベース (niph.go.jp) および新型コロナウイルス
感染症（COVID-19）の長期合併症の実態把握と病態生理解明に向けた基盤研究 | 厚生労働科学研究成果データベース (niph.
go.jp)
・Achkar M, et al. Post-COVID lung disease(s). Ann Thorac Med. Jul-Sep;17(3):137-144, 2022.
・Ackermann M, et al. Pulmonary vascular endothelialitis, thrombosis, and Angiogenesis in Covid-19. N Engl J Med.
383(2)：120-8, 2020.
・Alkodaymi MS, et al. Prevalence of post-acute COVID19 syndrome symptoms at different follow-up periods: a
systematic review and meta-analysis. Clin Microbiol Infect. May；28(5) : 657-666, 2022.
・Antoniou KM, et al. European respiratory society statement on long COVID-19 follow-up. Eur Respir J. Aug 4；
60(2) : 2102174, 2022.
・Ballering AV, et al. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort
study. Lancet. 400：452-61, 2022.
13：917886, 2022．
・Cheon IS, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol.Nov 12;6（65）：
eabk1741, 2021.
・Daines L, et al. Characteristics and risk factors for postCOVID-19 breathlessness after hospitalisation for
COVID-19. ERJ Open Res 2023; 9: 00274-2022 [DOI: 10.1183/23120541.00274-2022].
・Fabbri L, et al. Parenchymal lung abnormalities following hospitalisation for COVID-19 and viral pneumonitis:
a systematic review and meta-analysis.Thorax Mar 25 : thoraxjnl-2021-218275, 2022.
・Faverio P, et al. One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up
study. Respir Res.Mar. 21；23(1)： 65. 2022.
・Gencer A et al. Bronchodilator reversibility testing in long-term cough and dyspnea after Covid-19 viral infection:
a trigger for asthma? J Asthma 2023; 60(6):1221-1226
・Han X, et al. Longitudinal Assessment of Chest CT Findings and Pulmonary Function after COVID-19 Infection.
Radiology. 2023 Apr;307(2):e222888. doi: 10.1148/radiol.222888
・Huang L, et al. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal
cohort study. Lancet Respir Med. 2022 Sep;10(9):863-876.
・Jiménez-Rodríguez BM, et al. On the single and multiple associations of COVID-19 post-acute sequelae: 6-month
prospective cohort study. Sci Rep.Mar 1 ; 12（1）: 3402, 2022.
・Kanne JP, et al. Long-term Lung Abnormalities Associated with COVID-19 Pneumonia. Radiology. 2023
Feb;306(2):e221806. doi: 10.1148/radiol.221806.
・Mark Barash,& Vijaya Ramalingam. Post-COVID Interstitial Lung Disease and Other Lung Sequelae. Clin Chest
Med 2023;44(2):263-277
・Montani D, et al. COMEBAC Study Group.Post-acute COVID-19 syndrome. Eur Respir Rev Mar. 9；31(163)：
210185, 2022.
・Singh SJ et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to
clinical care and rehabilitation. Lancet Respir Med 2023 May 19;S2213-2600(23)00159-5. doi: 10.1016/S22132600(23)00159-5. Online ahead of print.
・Song WJ, et al. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral
neurotropism, neuroinflammation, and neuroimmune responses. Lancet Respir Med. Mayl；9(5)：533-544.2021.
・Stewart I et al. Residual Lung Abnormalities after COVID-19 Hospitalization Interim Analysis of the UKILD Post–
COVID-19 Study. Am J Respir Crit Care Med 2023;207(6):693-・Watanabe A, et al. One-year follow-up CT
findings in COVID-19 patients: A systematic review and meta-analysis. .Respirology. 2022 Aug;27(8):605-616.
・Wu X, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19related hospitalisation: a prospective study. Lancet Respir Med. Jul；9(7)：747-754. 2021.
◀︎目次
26